Doxycycline
| Doxycycline | |
|---|---|
| Salts [] | |
|---|---|
| Doxycycline phosphate | |
| Doxycycline hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 444.40 g/mol [1] |
| Melting point | 201 °C [1] |
| Solubility | 50 mg/mL [1] |
| Predicted LogP | -0.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C22H24N2O8 |
| IUPAC name | (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide |
| SMILES | C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O |
| InChI | InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25-27,30,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1 |
| InChIKey | SGKRLCUYIXIAHR-AKNGSSGZSA-N |
| CAS number | 564-25-0 |
| UNII | 334895S862 |
| PubChem CID | 54671203 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 10–22 hours |
| Metabolism | Negligible |
| Excretion | Mainly feces, 40% urine |
| Routes of administration | By mouth, intravenous |
Doxycycline (also known as Vibramycin, Doxytetracycline, Doxycycline (anhydrous), Doxycyclinum, Monodox, Doxiciclina, Doxycycline anhydrous, 6α-Deoxy-5-oxytetracycline, Vibra-tabs or Doxycycline hyclate) is a antibiotic substance of the phenol and aniline class.
Chemistry
Salts []
Stereochemistry []
Doxycycline is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Doxycycline matches Lipinski's rule of five (violations: 1).Pharmacology
ATC Classification
- (J01AA02)
Mechanism of action []
Protein synthesis is essential for survival and functioning of cells, including bacteria. Doxycycline inhibits bacterial protein synthesis by allosterically binding to the 30S prokaryotic ribosomal subunit. The drug blocks the association charged aminoacyl-tRNA (aa-tRNA) with the ribosomal A site, which is the acceptor site on the mRNA-ribosome complex. Doxycycline ultimately impedes the elongation phase of protein synthesis and halts the production of essential proteins for bacterial survival and functioning. Doxycycline mediates anti-inflammatory actions by preventing calcium-dependent microtubular assembly and lymphocytic proliferation, thereby inhibiting leukocyte movement during inflammation. It also inhibits nitric oxide synthase, which is an enzyme that produces nitric oxide, an inflammatory signaling molecule. [1]
Medical side effects []
30 side effects listed on drug labels in SIDER 4.1 (doxycycline).
- Anaphylactic shock
- Haemolytic anaemia
- Angioedema
- Decreased appetite
- Dysphagia
- Dermatitis exfoliative
- Diarrhoea
- Enterocolitis
- Eosinophilia
- Oesophagitis
- Dermatitis
- Rash
- Glossitis
- Hypersensitivity
- Systemic lupus erythematosus
- Nausea
- Neutropenia
- Pericarditis
- Henoch-Schonlein purpura
- Serum sickness
- Thrombocytopenia
- Urticaria
- Vomiting
- Intracranial pressure increased
- Oesophageal ulcer
- Fontanelle bulging
- Hepatotoxicity
- Photosensitivity reaction
- Menorrhagia
- Nephropathy toxic
Indications
- Actinomycosis
- Amoebic colitis
- Anthrax
- Bartonellosis
- Body temperature increased
- Brucellosis
- Chancroid
- Cholera
- Gonorrhoea
- Granuloma inguinale
- Inclusion conjunctivitis
- Infection
- Listeriosis
- Lymphogranuloma venereum
- Plague
- Pneumonia anthrax
- Psittacosis
- Q fever
- Relapsing fever
- Respiratory tract infection
- Rickettsialpox
- Rocky mountain spotted fever
- Syphilis
- Trachoma
- Trench mouth
- Tularaemia
- Typhus
- Unspecified non-gonococcal urethritis (NGU)
- Upper respiratory tract infection
- Urinary tract infection
- Yaws
Legal status []
- Australia: Doxycycline is a Schedule 4.
- United Kingdom: Doxycycline is Prescription only.
- United States: Doxycycline is Prescription only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 54671203, Doxycycline. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/54671203
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Doxycycline. UNII: 334895S862. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/334895S862
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:19:50 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 09:19:46 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:19:46 |
| gsrs | ok | 2026-11-20 09:19:47 |
| hmdb | missing (no HMDB id) | 2026-11-20 09:19:46 |
| kegg | ok | 2026-11-20 09:19:51 |
| pubchem | ok | 2026-11-20 09:19:46 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:19:46 | |
| sider | ok | 2026-11-20 09:19:46 |
| structure | ok | 2026-11-20 09:19:46 |
| wikipedia | ok | 2026-11-20 09:19:46 |